All Posts:translational research
-
Professor Makes Strides in Pancreatic Cancer Detection and Treatment
Pancreatic cancer has the lowest survival rate of all cancers. Jill Smith, MD, a member of Georgetown University’s Lombardi Comprehensive Cancer Center, is working to improve the disease’s grim statistics. Over the past decade, Smith, also a gastroenterologist and professor of medicine in the School of Medicine, has made discoveries in the lab that she’s working to translate to patients.
Category: GUMC Stories
-
Georgetown Researcher Develops Low-Cost Touchscreen Chamber for Mice
James O’Leary, PhD, a postdoctoral fellow in the Laboratory for Brain Injury and Dementia at Georgetown University Medical Center, constructed four touchscreen chambers for use in the lab for much less than the devices cost commercially.
Category: GUMC Stories
-
Surgeon and Basic Scientists Partner to Develop New Way to Suss Out Early Problems in Liver Transplantation
A unique collaboration between basic scientists at Georgetown University Medical Center and a transplant surgeon at MedStar Health could change how and when problems are identified with liver transplants, leading to expedited treatment and significantly reducing the need for additional testing.
Category: GUMC Stories
-
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Immunotherapy drugs alone have not shown to be responsive to pancreatic cancer.
Category: News Release